Home » Topics » BioWorld Science

BioWorld Science
RSS

New EAAT3 inhibitors divulged by Roche

May 10, 2018

Lundbeck updates pipeline progress of first quarter 2018

May 10, 2018

Syndax Pharmaceuticals describes preclinical activity of Menin/MLL1 inhibitor VTP-50469

May 10, 2018

Lodo Therapeutics and Genentech enter multi-target strategic collaboration

May 10, 2018

Escient Pharmaceuticals launches to advance first-in-class GPCR-targeted drugs

May 10, 2018

Novel NKCC1 inhibitor reduces brain damage after ischemic stroke in mice

May 10, 2018

Lipocine receives FDA complete response letter for Tlando

May 10, 2018

Provention Bio acquires rights to teplizumab and MGD-010 from MacroGenics

May 10, 2018

IGEM Therapeutics awarded grant from Innovate UK

May 10, 2018

AcelRx Pharmaceuticals resubmits Dsuvia NDA in U.S.

May 10, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...